Tumor Biomarker Testing for Metastatic Colorectal Cancer: a Canadian Consensus Practice Guideline

The systemic therapy management of metastatic colorectal cancer (mCRC) has evolved from primarily cytotoxic chemotherapies to now include targeted agents given alone or in combination with chemotherapy, and immune checkpoint inhibitors. A better understanding of the pathogenesis and molecular driver...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Irene S., Aubin, Francine, Goodwin, Rachel, Loree, Jonathan M., Mather, Cheryl, Sheffield, Brandon S., Snow, Stephanie, Gill, Sharlene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310231/
https://www.ncbi.nlm.nih.gov/pubmed/35898967
http://dx.doi.org/10.1177/17588359221111705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310231/
https://www.ncbi.nlm.nih.gov/pubmed/35898967
http://dx.doi.org/10.1177/17588359221111705

Ejemplares similares